The role of vitamin D in mineral and bone disorders of children in chronic kidney disease (literature review)

Authors

DOI:

https://doi.org/10.22141/2307-1257.14.2.2025.509

Keywords:

vitamin D, children, chronic kidney disease, chronic kidney disease — mineral and bone disorder, renal replacement therapy, review

Abstract

The article presents an analysis of theoretical and practical results of research in PubMed, MEDLINE, Embase, Scopus and Web of Science databases on the study of vitamin D metabolism and its role in the development of mineral and bone disorders in children with chronic kidney disease, assessment of potential nutritional needs and risk factors for the development of complications of mineral and bone metabolism on the background of nephrological pathology. The article focuses on the use of vitamin D in renal replacement therapy in pediatric patients.

Downloads

Download data is not yet available.

References

Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017 Jun;18(2):153-165. doi: 10.1007/s11154-017-9424-1.

Tice JA, Halalau A, Burke H. Vitamin D Does Not Prevent Cancer or Cardiovascular Disease: The VITAL Trial. J Gen Intern Med. 2020 Aug 12. doi: 10.1007/s11606-020-05648-x.

Fiamenghi VI, Mello ED. Vitamin D deficiency in children and adolescents with obesity: a meta-analysis. J Pediatr (Rio J). 2021 May-Jun;97(3):273-279. doi: 10.1016/j.jped.2020.08.006.

Oktaria V, Triasih R, Graham SM, et al. Vitamin D deficiency and severity of pneumonia in Indonesian children. PLoS One. 2021 Jul 9;16(7):e0254488. doi: 10.1371/journal.pone.0254488.

He LP, Song YX, Zhu T, Gu W, Liu CW. Progress in the Relationship between Vitamin D Deficiency and the Incidence of Type 1 Diabetes Mellitus in Children. J Diabetes Res. 2022 Sep 2;2022:5953562. doi: 10.1155/2022/5953562.

Konuksever D, Yücel Karakaya SP, Bölük O, Koçak M, Kılıç BO, Saç RÜ. The association of vitamin D deficiency with hemogram-derived inflammatory biomarkers in children. Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2418-2423. doi: 10.1016/j.numecd.2022.07.012.

Płudowski P, Kos-Kudła B, Walczak M, et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023 Jan 30;15(3):695. doi: 10.3390/nu15030695.

Johnson CR, Thacher TD. Vitamin D: immune function, inflammation, infections and auto-immunity. Paediatr Int Child Health. 2023 Nov;43(4):29-39. doi: 10.1080/20469047.2023.2171759.

Liu Z, Huang S, Yuan X, Wang Y, Liu Y, Zhou J. The role of vitamin D deficiency in the development of paediatric diseases. Ann Med. 2023 Dec;55(1):127-135. doi: 10.1080/07853890.2022.2154381.

Alenazi KA, Alanezi AA. Prevalence of Vitamin D Deficiency in Children With Cerebral Palsy: A Meta-Analysis. Pediatr Neurol. 2024 Oct;159:56-61. doi: 10.1016/j.pediatrneurol.2024.03.021.

Bahardoust M, Salari S, Ghotbi N, et al. Association between prenatal vitamin D deficiency with dental caries in infants and children: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Apr 8;24(1):256. doi: 10.1186/s12884-024-06477-0.

Jørgensen HS, Vervloet M, Cavalier E, et al. The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement. Nephrol Dial Transplant. 2025 Apr 1;40(4):797-822. doi: 10.1093/ndt/gfae293.

Rykova OV, Zaft VB, Zaft AA, Klimova ZO, Boyko IV, Galytska VV. Problem of vitamin D deficiency. Reproductive Endocrinology. 2015;(23):75-78. Ukrainian. doi: 10.18370/2309-4117.2015.23.75-78.

Kaminsky OV. Vitamin D dosage. Miznarodnij endokrinologichnij zurnal. 2021;17(5):435-442. Ukrainian. doi: 10.22141/2224-0721.17.5.2021.241524.

Dedukh NV, Grygorieva NV. The role of vitamin d in the functioning of bone cells. Fiziol Zh. 2023;69(6):108-119. Ukrainian. doi: 10.15407/fz69.06.108.

Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016 Jan;96(1):365-408. doi: 10.1152/physrev.00014.2015.

Yamada S, Nakano T. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD. J Atheroscler Thromb. 2023 Aug 1;30(8):835-850. doi: 10.5551/jat.RV22006.

Bouillon R, Bikle D. Vitamin D Metabolism Revised: Fall of Dogmas. J Bone Miner Res. 2019 Nov;34(11):1985-1992. doi: 10.1002/jbmr.3884.

Pike JW, Meyer MB. The unsettled science of nonrenal calcitriol production and its clinical relevance. J Clin Invest. 2020 Sep 1;130(9):4519-4521. doi: 10.1172/JCI141334.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.

Jean G, Souberbielle JC, Chazot C. Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients. 2017 Mar 25;9(4):328. doi: 10.3390/nu9040328.

Banerjee S, Basu S, Sen A, Sengupta J. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2017 Nov;32(11):2063-2070. doi: 10.1007/s00467-017-3716-2.

Villafuerte-Ledesma HM, Moragrega B, Castillón E, Luzón-Alonso M, García-Mena M. Association between vitamin D serum levels and inflammatory markers in patients on hemodialysis. Gac Med Mex. 2020;156(6):509-515. doi: 10.24875/GMM.M21000452.

Matsumoto AK, Maes M, Michelin AP, et al. Vitamin D deficiency is not associated with increased oxidative stress in chronic kidney disease pre-dialysis patients. J Bras Nefrol. 2020 Oct-Dec;42(4):420-428. doi: 10.1590/2175-8239-JBN-2019-0156.

Banerjee S, Basu S, Akhtar S, Sinha R, Sen A, Sengupta J. Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls. Pediatr Nephrol. 2020 Mar;35(3):447-454. doi: 10.1007/s00467-019-04433-1.

Maji M, Kumar M, Chacham S, Mirza AA, Bhat NK, Mandal S. Severity of Vitamin D Deficiency in Children with Nephrotic Syndrome: A Study from Tertiary Care Center in Northern India. Saudi J Kidney Dis Transpl. 2022 Sep 1;33(5):608-616. doi: 10.4103/1319-2442.389421.

Visiedo L, Pérez Abud R, Rivas-Ruiz F, et al. Hypovitaminosis D and its relationship with nutritional status and quality of life in patients undergoing haemodialysis. Nutr Hosp. 2023 Feb 15;40(1):144-150. doi: 10.20960/nh.04150.

Hsu S, Zelnick LR, Lin YS, et al. Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study. J Am Soc Nephrol. 2021 Jan;32(1):188-198. doi: 10.1681/ASN.2020050625.

Ginsberg C, Hoofnagle AN, Katz R, et al. The Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein Concentration. Clin Chem. 2021 Jan 30;67(2):385-393. doi: 10.1093/clinchem/hvaa238.

Hsu S, Zelnick LR, Lin YS, et al. Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance. J Steroid Biochem Mol Biol. 2022 Mar;217:106047. doi: 10.1016/j.jsbmb.2021.106047.

Ishimine N, Wu S, Ota R, et al. Development of free 25-hydroxyvitamin D3 assay method using liquid chromatography-tandem mass spectrometry. Biosci Rep. 2022 Oct 28;42(10):BSR20221326. doi: 10.1042/BSR20221326.

Lee S, Chung HJ, Jung S, et al. 24,25-Dihydroxy Vitamin D and Vitamin D Metabolite Ratio as Biomarkers of Vitamin D in Chronic Kidney Disease. Nutrients. 2023 Jan 22;15(3):578. doi: 10.3390/nu15030578.

Hsu S, Zelnick LR, Bansal N, et al.; CRIC Study Investigators. Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2023 Jul 18;12(14):e028561. doi: 10.1161/JAHA.122.028561.

Shroff R, Wan M, Gullett A, et al. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol. 2012 Feb;7(2):216-223. doi: 10.2215/CJN.04760511.

Gravesen E, Hofman-Bang J, Lewin E, Olgaard K. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5. Scand J Clin Lab Invest. 2013 Mar;73(2):107-116. doi: 10.3109/00365513.2012.744464.

Dreyer G, Tucker AT, Harwood SM, Pearse RM, Raftery MJ, Yaqoob MM. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial. PLoS One. 2014 Jul 9;9(7):e99461. doi: 10.1371/journal.pone.0099461.

Bhan I, Dobens D, Tamez H, et al. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015 Apr 7;10(4):611-619. doi: 10.2215/CJN.06910714.

Wetmore JB, Kimber C, Mahnken JD, Stubbs JR. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Br J Nutr. 2016 Dec;116(12):2074-2081. doi: 10.1017/S000711451600427X.

Zhang D, Li H, Yin D, Wang L, Ma Y. Ergocalciferol versus calcitriol for controlling chronic kidney disease mineral bone disorder in stage 3 to 5 CKD: A randomized controlled trial. Eur J Pharmacol. 2016 Oct 15;789:127-133. doi: 10.1016/j.ejphar.2016.07.019.

Sprague SM, Crawford PW, Melnick JZ, et al. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol. 2016;44(4):316-325. doi: 10.1159/000450766.

Batacchi Z, Robinson-Cohen C, Hoofnagle AN, et al. Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1498-1506. doi: 10.2215/CJN.00530117.

Strugnell SA, Csomor P, Ashfaq A, Bishop CW. Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease. Kidney Dis (Basel). 2023 Feb 10;9(3):206-217. doi: 10.1159/000529523.

Bezruk VV, Andriychuk TP, Ivanov DD, Fomina SP, Shkrobanets ІD. Standardization of medical care provision to children: local clinical protocol of medical care for children with glomerulonephritis at the level of the hospital district. Kidneys. 2024 Mar 14;13(1):2-17. Ukrainian. doi: 10.22141/2307-1257.13.1.2024.436.

Christodoulou M, Aspray TJ, Schoenmakers I. Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines. Calcif Tissue Int. 2021 Aug;109(2):157-178. doi: 10.1007/s00223-021-00844-1.

Shroff R, Wan M, Nagler EV, et al.; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant. 2017 Jul 1;32(7):1098-1113. doi: 10.1093/ndt/gfx065.

Magagnoli L, Cassia M, Galassi A, et al. Vitamin D: are all compounds equal? Clin Kidney J. 2025 Mar 13;18(Suppl 1):i61-i96. doi: 10.1093/ckj/sfae417.

Torregrosa JV, Bover J, Rodríguez Portillo M, et al. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM). Nefrologia (Engl Ed). 2023 Jun;43(Suppl 1):1-36. doi: 10.1016/j.nefroe.2023.03.003.

Frazão JM, Elangovan L, Maung HM, et al. Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis. 2000 Sep;36(3):550-561. doi: 10.1053/ajkd.2000.16193.

Dennis VC, Albertson GL. Doxercalciferol treatment of secondary hyperparathyroidism. Ann Pharmacother. 2006 Nov;40(11):1955-1965. doi: 10.1345/aph.1G523.

Gozhenko AI, Ivanov DD. What can a tandem of a pathophysiologist and a clinician bring to clinical practice? Kidneys. 2024;13(2):96-100. Ukrainian. doi: 10.22141/2307-1257.13.2.2024.451.

Downloads

Published

2025-05-02

How to Cite

Bezruk, V., Ivanov, D., Shkrobanets, I., Olenovych, O., Makarova О., Kaushanska О., & Seman-Minko, I. (2025). The role of vitamin D in mineral and bone disorders of children in chronic kidney disease (literature review). KIDNEYS, 14(2), 154–160. https://doi.org/10.22141/2307-1257.14.2.2025.509

Issue

Vol. 14 No. 2 (2025)

Section

Reviews

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.